The global Pancreatic Cancer Therapeutics and Diagnostic Market is estimated to be valued at US$ 3,689.6 Mn in 2022 and is expected to exhibit a CAGR of 7.4% over the forecast period 2023-2028, as highlighted in a new report published by Coherent Market Insights.Market Overview:Pancreatic cancer is one of the deadliest forms of cancer, with a low survival rate. The market for pancreatic cancer...
Market Dynamics: The pancreatic cancer therapeutics and diagnostic market is primarily driven by rising incidence of pancreatic cancer globally. According to the National Cancer Institute, it is estimated that around 60,430 Americans will be diagnosed with pancreatic cancer in 2022. Other key drivers include growing geriatric population, increasing adoption of imaging modalities for diagnosis...
Pancreatic cancer is a type of cancer that develops in the pancreas, a gland located behind the stomach and next to the small intestine and liver. Pancreatic cancer therapies and diagnostics play an important role in early detection and treatment. Therapeutic and diagnostic options help in improving the survival rate and quality of life of patients.
Market key trends:
One of the key...